Oscar Health Q2 EPS $(0.07) Beats $(0.27) Estimate, Sales $1.52B Beat $1.44B Estimate
Portfolio Pulse from Benzinga Newsdesk
Oscar Health (NYSE:OSCR) reported Q2 earnings per share of $(0.07), beating the analyst consensus estimate of $(0.27) by 74.07%. This is an 86.79% increase over losses from the same period last year. The company also reported quarterly sales of $1.52 billion, beating the analyst consensus estimate of $1.44 billion by 5.63%, a 49.56% increase over sales from the same period last year.
August 08, 2023 | 9:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health's Q2 earnings and sales beat analyst estimates, which could positively impact the stock.
Oscar Health reported better than expected Q2 earnings and sales, which could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100